Transition State Analogue Inhibitors of N-Ribosyltransferases

Iminosugars: From Synthesis to Therapeutic Applications

Volumn , Issue , 2008, Pages 177-208

  Schramm, Vern L ^a   Tyler, Peter C ^b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b CALLAGHAN INNOVATION   (New Zealand)

Author keywords

Chronic lymphocytic leukaemia; Enzyme inhibitor complexes; Iminoribitol sugar; Inosine uridine nucleoside hydrolase; Kinetic isotope effects; Nucleoside hydrolases and protozoan parasites; Purine nucleoside phosphorylases; Ribosomal protein production function; Ricin immunochemotherapy; Spermidine and spermine synthases inhibition

Indexed keywords

EID: 84881377370     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470517437.ch8     Document Type: Chapter

References (85)

1. Zewail A. H. (2000) Femtochemistry: atomic-scale dynamics of the chemical bond using ultrafast lasers (Nobel Lecture). Angew Chem. Int. Ed. Engl., 39, 2586-2631.
2. Cleland, W.W. (1982) The use of isotope effects to determine transition-state structure for enzymic reactions. Methods Enzymol., 87, 625-641.
3. Rodgers, J., Femec, D.A. and Schowen, R.L. (1982) Isotopic mapping of transition-state structural features associated with enzymatic catalysis of methyl transfer. J. Am. Chem. Soc., 104, 3263-3268.
4. Schramm, V.L. (1998) Enzymatic transition states and transition state analogue design. Ann. Rev. Biochem., 67, 693-720.
5. Gao, J., Ma, S., Major, D. T., Nam, K., Pu, J. and Truhlar, D. G. (2006) Mechanisms and free energies of enzymatic reactions. Chem. Rev., 106, 3188-3209.
6. Pu, J., Gao, J. and Truhlar, D. G. (2006) Multidimensional tunneling, recrossing, and the transmission coefficient for enzymatic reactions. Chem. Rev., 106, 3140-3169.
7. Antoniou, D., Basner, J., Nunez, S. and Schwartz, S. D. (2006) Computational and theoretical methods to explore the relation between enzyme dynamics and catalysis. Chem. Rev., 106, 3170-3187.
8. Pauling, L. (1948) Chemical achievement and hope for the future. Amer. Sci., 36, 50-58.
9. Eyring, H. and Johnson, F. H. (1971) The elastomeric rack in biology. Proc. Natl. Acad. Sci. USA, 68, 2341-2344.
10. Jencks, W.P. (1975) Binding energy, specificity, and enzymatic catalysis: the Circe effect. Adv. Enzymol., 43, 219-410.
11. Wolfenden, R. (1969) Transition state analogues for enzyme catalysis. Nature, 223, 704-705.
12. Leinhard, G. E. (1973) Enzymatic catalysis and transition-state theory. Science, 180, 149-154.
13. Jencks, W. P. (1987) Economics of enzyme catalysis. Cold Spring Harb. Symp. Quant. Biol., 52, 65-73.
14. Schowen, K. B., Limbach, H. H., Denisov, G. S. and Schowen, R. L. (2000) Hydrogen bonds and proton transfer in general-catalytic transition-state stabilization in enzyme catalysis. Biochem. Biophys. Acta, 1458, 43-62.
15. Schramm, V.L. (1998) Enzymatic transition states and transition state analogue design. Ann. Rev. Biochem., 67, 693-720.
16. Schramm, V.L. (1999) Enzymatic transition-state analysis and transition-state analogs. Methods Enzymol., 308, 301-355.
17. Schramm, V. L. (2005) Enzymatic transition states: thermodynamics, dynamics and analogue design. Arch. Biochem. Biophys., 433, 13-26.
18. Horenstein, B.A., Parkin, D.W., Estupinan, B. and Schramm, V.L. (1991) Transition-state analysis of nucleoside hydrolase from Crithidia fasciculata. Biochemistry, 30, 10788-10795.
19. Schramm, V. L. (2003) Enzymatic transition state poise and transition state analogues. Acc. Chem. Res., 36, 588-596.
20. Kline, P.C. and Schramm, V.L. (1993) Purine nucleoside phosphorylase. Catalytic mechanism and transition state analysis of the arsenolysis reaction. Biochemistry, 32, 13212-13219.
21. Lewandowicz, A. and Schramm, V. L. (2004) Transition state analysis for human and Plasmodium falciparum purine nucleoside phosphorylases. Biochemistry, 43, 1458-1468.
22. Singh, V. and Schramm, V. L. (2006) Transition state structure of human 5'-methylthioadenosine phosphorylase. J. Am. Chem. Soc., 128, 14691-14696.
23. Singh, V., Lee, J. E., Nunez, S., Howell, P. L. and Schramm, V. L. (2005) Transition state structure of 5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase from Escherichia coli and its similarity to transition state analogues. Biochemistry, 44, 11647-11659.
24. Singh, V. and Schramm, V. L. (2007) Transition state structure of. pneumoniae 5'-methylthioadenosine phosphorylase. J. Am. Chem. Soc., 129, 2783-2795.
25. Chen, X.-Y., Berti, P. J. and Schramm, V. L. (2000) Ricin A-chain: kinetic isotope effects and transition state structures with stem-loop RNA. J. Am. Chem. Soc., 122, 1609-1617.
26. Chen, X.-Y., Berti, P.J. and Schramm, V. L. (2000) Transition state structure for depurination of DNA by ricin A-chain. J. Am. Chem. Soc., 122, 6527-6534.
27. Cherian, X. M., Van Arman, S. A. and Czarnik, A. W. (1990) Models for nucleoside glycosylase enzymes. Evidence that the hydrolysis of α-D-Ribofuranosides requires a "backside" preassociated nucleophile. J. Am. Chem. Soc., 112, 4490-4498.
28. Mazzella, L. J., Parkin, D. W., Tyler, P. C., Furneaux, R. H. and Schramm, V. L. (1996) Mechanistic diagnoses for N-ribohydrolases and purine nucleoside phosphorylase. J. Am. Chem. Soc., 118, 2111-2112.
29. Parkin, D. W., Limberg, G., Tyler, P. C. Furneaux, R. H., Chen, X.-Y. and Schramm, V.L. (1997) Isozyme-specific transition state inhibitors for the trypanosomal nucleoside hydrolases. Biochemistry, 36, 3528-3534.
30. Sauve, A. A., Cahill, S. M., Zech, S. G., Basso, L.A., Lewandowicz, A., Santos, D. S., Grubmeyer, C., Evans, G. B., Furneaux, R. H., Tyler, P. C., McDermott, A., Girvin, M. E. and Schramm, V. L. (2003) Ionic states of substrates and transition state analogues at the catalytic sites of N-ribosyltransferases. Biochemistry, 42, 5694-5705.
31. Parkin D. W. (1996) Purine-specific nucleoside N-ribohydrolase from Trypanosoma brucei brucei. Purification, specificity, and kinetic mechanism. J. Biol. Chem., 271, 21713-21719.
32. Schramm V. L. and Tyler, P. C. (2003) Imino-sugar-based nucleosides. Curr. Top. Med. Chem., 3, 525-540.
33. Estupiñán, B. and Schramm, V.L. (1994) Guanosine-inosine preferring nucleoside N-glycohydrolase from Crithidia fasciculata. J. Biol. Chem., 269, 23068-23073.
34. Horenstein, B.A., Abdulah, D.R., Estupiñán, B. and Schramm, V.L. (1991) Nucleoside hydrolase from Crithidia fasciculata. Metabolic role, purification, specificity, and kinetic mechanism. J. Biol. Chem., 266, 20658-20665.
35. Giblett, E. R., Ammann, A. J., Wara, D. W., Sandman, R. and Diamond, L. K. (1975) Nucleoside-phosphorylase deficiency in a child with severely defective T-cell immunity and normal B-cell immunity. Lancet, 1, 1010-1013.
36. Montgomery, J.A., Niwas, S., Rose, J.D., Secrist III, J.A., Babu, Y.S., Bugg, C.E., Erion, M.D., Guida, W.C. and Ealick, S.E. (1993) Structure-based design of inhibitors of purine nucleoside phosphoryla. 1. 9-(Arylmethyl) derivatives of 9-deaza-aguanine. J. Med. Chem., 36, 55-69.
37. Morris, P.E. Jr, and Montgomery, J.A. (1998) Inhibitors of the enzyme purine nucleoside phosphorylase. Exp. Opin. Ther. Patents, 8, 283-299.
38. Stoeckler, J.D., Ealick, S.E., Bugg, C.E. and Parks, R.E., Jr. (1986) Design of purine nucleoside phosphorylase inhibitors. Fed. Proc., Fed. Am. Soc. Exp. Biol., 45, 2773-2778.
39. Ealick, S.E., Babu, Y.S., Bugg, C.E., Erion, M.D., Guida, W.C., Montgomery, J.A. and Secrist III, J.A. (1991) Application of crystallographic and modeling methods in the design of purine nucleoside phosphorylase inhibitors. Proc. Natl. Acad. Sci. USA, 88, 11540-11544.
40. Ullman, B., Cohen, A. and Martin, D. W. (1976) Characterization of a cell culture model for the study of adenosine deaminase-and purine nucleoside phosphorylase-deficient immunologic disease. Cell, 9, 205-211.
41. Carson, D.A. and Kaye, J. (1978) Deoxyribonucleoside toxicity in adenosine deaminase and purine nucleoside phosphorylase deficiency: implications for the development of new immunosuppressive agents. Ciba Found. Symp. 1978, 115-133.
42. Morris, P.E. Jr. and Omura, G. A. (2000) Inhibitors of the enzyme purine nucleoside phosphorylase as potential therapy for psoriasis. Curr. Pharm. Des., 6, 943-959.
43. Duvic, M., Olsen, E. A., Omura, G. A., Maize, J. C., Vonderheid, E. C., Elmets, C. A., Shupack, J. L., Demierre, M. F., Kuzel, T. M. and Sanders, D. Y. (2001) A phase III, randomized, double-blind, placebo-controlled study of peldesine (BCX-34) cream as topical therapy for cutaneous T-cell lymphoma. J. Am. Acad. Dermatol., 44, 940-947.
44. Biggar, W. D., Giblett, E. R., Ozere, R. L. and Grover, B. D. (1978) A new form of nucleoside phosphorylase deficiency in two brothers with defective T-cell function. J. Pediatr., 92, 354-357.
45. Mohamedali, K.A., Guicherit, O.M., Kellems, R.E. and Rudolph, F.B. (1993) The highest levels of purine catabolic enzymes in mice are present in the proximal small intestine. J. Biol. Chem., 268, 23728-23733.
46. Trager, W. (1971) Malaria parasites (Plasmodium lophurae) developing extracellularly in vitro: incorporation of labeled precursors. J. Protozool., 18, 392-399.
47. Gardner, M. J., Hall, N., Fung, E., White, O., Berriman, M., Hyman, R.W., Carlton, J. M., Pain, A., Nelson, K. E., Bowman, S. et al. (2002) The genome sequence of the human malaria parasite Plasmodium falciparum. Nature, 419, 498-511.
48. Kicska, G. A., Tyler, P. C., Evans, G. B., Furneaux, R. H., Schramm, V. L. and Kim, K. (2002) Purine-less death in Plasmodium falciparum induced by immucillin-H, a transition state analogue of purine nucleoside phosphorylase. J. Biol. Chem., 277, 3226-3231.
49. Shi, W., Ting, L. M., Kicska, G. A., Lewandowicz, A., Tyler, P. C., Evans, G. B., Furneaux, R. H., Kim, K., Almo, S. C. and Schramm, V. L. (2004) Plasmodium falciparum purine nucleoside phosphorylase: crystal structures, immucillin inhibitors, and dual catalytic function. J. Biol. Chem., 279, 18103-18106.
50. Lewandowicz, A., Ringia, E. A., Ting, L. M., Kim, K., Tyler, P. C., Evans, G. B., Zubkova, O. V., Mee, S., Painter, G. F., Lenz, D. H., Furneaux, R. H. and Schramm, V. L. (2005) Energetic mapping of transition state analogue interactions with human and Plasmodium falciparum purine nucleoside phosphorylases. J. Biol. Chem., 280, 30320-30328.
51. Miles, R. W., Tyler, P. C., Furneaux, R. H., Bagdassarian, C. K. and Schramm, V. L. (1998) One-third-the-sites transition state inhibitors for purine nucleoside phosphorylase. Biochemistry, 37, 8615-8621.
52. Kicska, G. A., Tyler, P. C., Evans, G. B., Furneaux, R. H., Shi, W., Fedorov, A., Lewandowicz, A., Cahill, S. M., Almo, S. C. and Schramm, V. L. (2002) Atomic dissection of the hydrogen bond network for transition-state analogue binding to purine nucleoside phosphorylase. Biochemistry, 41, 14489-14498.
53. Lewandowicz, A., Tyler, P. C., Evans, G. B., Furneaux, R. H. and Schramm, V. L. (2003) Achieving the ultimate physiological goal in transition state analogue inhibitors for purine nucleoside phosphorylase. J. Biol. Chem., 278, 31465-31468.
54. Kilpatrick, J. M., Morris, P. E., Serota, D.G., Jr., Phillips, D., Moore, D. R., Bennett, J. C. and Babu, Y. S. (2003) Intravenous and oral pharmacokinetic study of BCX-1777, a novel purine nucleoside phosphorylase transition-state inhibitor. In vivo effects on blood 2'-deoxyguanosine in primates. Int. Immunopharmacol., 3, 541-548.
55. http://www.biocryst.com/bcx_1777.htm (29 April 2007)
56. http://www.biocryst.com/bcx_4208.htm (29 April 2007)
57. El Bissati, K., Zufferey, R., Witola, W. H., Carter, N. S., Ullman, B. and Ben Mamoun, C. (2006) The plasma membrane permease PfNT1 is essential for purine salvage in the human malaria parasite Plasmodium falciparum. Proc. Natl. Acad. Sci. U. S. A., 103, 9286-9291.
58. Singh, V., Shi, W., Evans, G. B., Tyler, P. C., Furneaux, R. H., Almo, S. C. and Schramm, V. L. (2004) Picomolar transition state analogue inhibitors of human 5'-methylthioadenosine phosphorylase and X-ray structure with MT-immucillin-A. Biochemistry, 43, 9-18.
59. Singh, V., Evans, G. B., Lenz, D. H., Mason, J. M., Clinch, K., Mee, S., Painter, G. F., Tyler, P. C., Furneaux, R. H., Lee, J. E., Howell, P. L. and Schramm, V. L. (2005) Femtomolar transition state analogue inhibitors of 5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase from Escherichia coli. J. Biol. Chem., 280, 18265-18273.
60. Persson, T., Givskov, M. and Nielsen, J. (2005) Quorum sensing inhibition: targeting chemical communication in gram-negative bacteria. Curr. Med. Chem., 12, 3103-3115.
61. Casero, R. A., Jr., Frydman, B., Stewart, T.M. and Woster, P.M. (2005) Significance of targeting polyamine metabolism as an antineoplastic strategy: unique targets for polyamine analogues. Proc. West. Pharmacol. Soc., 48, 24-30.
62. Zhu, J. and Mekalanos, J. J. (2003) Quorum sensing-dependent biofilms enhance colonization in Vibrio cholerae. Dev. Cell., 5, 647-656.
63. Joyce, E. A., Kawale, A., Censini, S., Kim, C. C., Covacci, A. and Falkow, S. (2004) LuxS is required for persistent pneumococcal carriage and expression of virulence and biosynthesis genes. Infect. Immun., 72, 2964-2975.
64. Winzer, K., Sun, Y., Green, A., Delory, M., Blackley, D., Hardie, K. R., Baldwin, T. J. and Tang, C. M. (2002) Role of Neisseria meningitidis luxS in cell-to-cell signaling and bacteremic infection. Infect. Immun., 70, 2245-2248.
65. Mittal, R., Sharma, S., Chhibber, S. and Harjai, K. (2006) Contribution of quorum-sensing systems to virulence of Pseudomonas aeruginosa in an experimental pyelonephritis model. J. Microbiol. Immunol. Infect., 39, 302-309.
66. Lord, J.M., Roberts, L. M. and Robertus, J. D. (1994) Ricin: structure, mode of action, and some current applications. FASEB J., 8, 201-208.
67. Crompton, R. and Gall, D. (1980) Georgi Markov-death in a pellet. Med. Leg. J., 48, 51-62.
68. Frankel, A. E. and Kreitman, R. J. (2005) CLL immunotoxins. Leuk. Res., 29, 985-986.
69. Kreitman, R. J. (2001) Toxin-labeled monoclonal antibodies. Curr. Pharm. Biotechnol., 2, 313-325.
70. Schnell, R., Borchmann, P., Staak, J. O., Schindler, J., Ghetie, V., Vitetta, E. S. and Engert, A. (2003) Clinical evaluation of ricin A-chain immunotoxins in patients with Hodgkin's lymphoma. Ann. Oncol., 14, 729-736.
71. Tanaka, K. S. E, Chen, X.-Y, Ichikawa, Y., Tyler, P. C., Furneaux, R. H. and Schramm, V.L. (2001) Ricin A-chain inhibitors resembling the oxacarbenium ion transition state. Biochemistry, 40, 6845-6851.
72. Chen, X.-Y., Link, T. M. and Schramm, V. L. (1998) Ricin A-chain: kinetics, mechanism and RNA-stem-loop inhibitors. Biochemistry, 37, 11605-11613.
73. Roday, S., Amukele, T., Evans, G. B., Tyler, P. C., Furneaux, R. H. and Schramm, V. L. (2004) Inhibition of ricin A-chain with pyrrolidine mimics of the oxacarbenium ion transition state. Biochemistry, 43, 4923-4933.
74. Fleet, G. W. J. and Son, J. C. (1988) Polyhydroxylated pyrrolidines from sugar lactones: Synthesis of 1,4-dideoxy-1,4-imino-d-glucitol from d-galactonolactone and synthesis of 1,4-dideoxy-1,4-imino-d-allitol, 1,4-dideoxy-1,4-imino-d-ribitol and (2S,3R,4S)-3,4-dihydroxyproline from d-gulonolactone. Tetrahedron, 44, 2637-2647.
75. Horenstein, B. A., Zabinski, R. F. and Schramm, V.L. (1993) A new class of C-nucleoside analogues. 1-(S)-1,4-dideoxy-1,4-imino-d-ribitols, transition state analogue inhibitors of nucleoside hydrolase. Tetrahedron Lett., 34, 7213-7216.
76. Furneaux, R. H., Schramm, V. L. and Tyler, P. C. (1999) Transition state analogue inhibitors of protozoa nucleoside hydrolases. Bioorg. Med. Chem., 11, 2599-2606.
77. Evans, G. B., Furneaux, R. H., Hutchison, T. L., Kezar, H. S., Morris, P.E., Jr., Schramm, V. L. and Tyler, P. C. (2001) Addition of lithiated 9-deazapurine derivatives to a carbohydrate cyclic imine: convergent synthesis of the aza-C-nucleoside immucillins. J. Org. Chem., 66, 5723-5730.
78. Furneaux, R. H. and Tyler, P. C. (1999) Improved syntheses of 3H,5H-pyrrolo[3,2-d]pyrimidines. J. Org. Chem., 64, 8411-8412.
79. Evans, G. B., Furneaux, R. H., Tyler, P. C. and Schramm, V. L. (2003) Synthesis of a transition state analogue inhibitor of purine nucleoside phosphorylase via the Mannich reaction. Org. Lett., 5, 3639-3640.
80. Evans, G. B., Furneaux, R. H., Lewandowicz, A., Schramm, V. L. and Tyler, P. C. (2003) Synthesis of second-generation transition state analogues of human purine nucleoside phosphorylase. J. Med. Chem., 46, 5271-5276.
81. Evans, G. B., Furneaux, R. H., Schramm, V. L., Singh, V. and Tyler, P. C. (2004) Targeting the polyamine pathway with transition-state analogue inhibitors of 5'-methylthioadenosine phosphorylase. J. Med. Chem., 47, 3275-3281.
82. Evans, G. B., Furneaux, R. H., Lenz, D. H., Painter, G. F., Schramm, V. L., Singh, V. and Tyler, P. C. (2005) Second generation transition state analogue inhibitors of human 5'-methylthioadenosine phosphorylase. J. Med. Chem., 48, 4679-4689.
83. Evans, G. B. (2004) The synthesis of N-ribosyl transferase inhibitors based on a transition state blueprint. Aust. J. Chem., 57, 837-854.
84. Singh, V., Shi, W., Almo, S. C., Evans, G. B., Furneaux, R. H., Tyler, P. C., Painter, G. F., Lenz, D. H., Mee, S., Zheng, R. and Schramm, V. L. (2006) Structure and inhibition of a quorum sensing target from Streptococcus Pneumoniae. Biochemistry, 45, 12929-12941.
85. Sturm, M. B., Roday, S. and Schramm, V. L. (2007) Circular DNA and DNA/RNA hybrid molecules as scaffolds for ricin inhibitor design. J. Am. Chem. Soc., 129, 5544-5550.